AbbVie/Alector: Another Alzheimer's Treatment Dumped

Congress Urges Action Against Pharma 340B Violators

FDA review of Amylyx's ALS treatment scheduled for September

Would the Merck / Seagen Merger Pass Tougher Regulatory Scrutiny?

By Reducing Barriers, DCTs Improve Patient Access To Oncology Trials

ASCO: Breakthroughs in Cancer Care Will Drive Change

Pharmaceutical Task Force to Unveil Findings on Merger Rules

Growing Partnerships With Digital Health Companies Signal Shift in Strategy

Pages